More Articles

July 16, 2018 | Heart Failure
In the U.S., candidates for heart transplantation are prioritized by the intensity of treatment they’ve received, potentially leading some centers to overtreat patients.
In an era of clinician shortages, those living in rural areas are at risk of not receiving needed care. Cardiologists are stepping up, but will it be enough?
July 16, 2018 | Practice Management
Troponin has become a widely accepted cardiac biomarker for myocardial infarction patients admitted to emergency rooms. But just how reliable is troponin in determining if a heart attack is really a heart attack?
Improving the use of ICDs will involve discerning appropriate from inappropriate shocks, standardizing post-shock protocols and refining device programming.
July 16, 2018 | Imaging
Interest in Tc 99m PYP is growing as new therapies for cardiac amyloidosis show promise in late-stage clinical trials.
July 16, 2018 | Hypertension
The FDA on Friday, July 13, joined more than 20 other countries in recalling medications containing valsartan, an active ingredient used to treat hypertension and heart failure. Some of the medications with valsartan have been contaminated with N-nitrosodimethylamine (NDMA), a probable human carcinogen.
July 16, 2018 | Practice Management
In the era of the Quadruple Aim, there’s no shortage of studies, media coverage and commentary on how our healthcare systems may be overusing resources.
Women and black patients have higher coronary artery bypass grafting (CABG) mortality rates than men and white patients, according to new research published in the Journal of the American Heart Association.
July 16, 2018 | Practice Management
Santa Fe cardiologist Roy Heilbron, MD, has been sentenced to more than four years in prison for medical fraud and obstruction of justice. He pleaded guilty to fraud last year.
July 13, 2018 | Hypertension
The average blood pressure of American youths is declining, a new CDC report suggests, even as updated guidelines classify almost 800,000 more of them as hypertensive.
July 13, 2018 | Heart Failure
A new study, published July 11 in the Journal of the American Medical Association, suggests heart failure (HF) may be moderately hereditary.
July 13, 2018 | Lipids & Metabolic
A tuberculosis vaccine that has been around for a century is being investigated as a potential low-cost, long-term treatment for type 1 diabetes.
Non-vitamin K antagonist oral anticoagulants may be even more effective for treating women with atrial fibrillation (AFib) than men, suggests a real-world study from Hong Kong published in the Journal of the American College of Cardiology.
CMS proposed several changes to its Medicare billing standards July 12, including paying doctors for virtual visits and alleviating some of their administrative burden.
July 13, 2018 | Hypertension
Adoption of the new 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines would result in a “substantial” increase in the prevalence of hypertension in both the U.S. and China.
July 12, 2018 | Lipids & Metabolic
A team of researchers used genome editing to inactivate the PCSK9 protein in the livers of rhesus macaque monkeys, resulting in 30 to 60 percent reductions in LDL cholesterol and even more significant drops in PCSK9 levels.
July 12, 2018 | Lipids & Metabolic
A new study published in the European Heart Journal suggests a particular quality of LDL cholesterol—not just the concentration of it—influences a patient’s risk of cardiovascular disease.
The more a person smokes, the greater the risk of developing a heart rhythm disorder, according to a new study published July 11 in the European Journal of Preventive Cardiology.
The FDA has approved the third generation of the MitraClip, which treats mitral regurgitation without open-heart surgery, device manufacturer Abbott announced July 12.
July 12, 2018 | Practice Management
A new survey from University of Utah Health revealed that most physicians feel responsible for educating patients about the cost of care but don’t believe they should be held accountable for it.